CurifyLabs  

Atlanta,  GA 
United States
https://www.curifylabs.com

Profile

CurifyLabs Compounding System Solution (CSS) is an automated pharmaceutical compounding platform for non-sterile dosage forms, including tablets, troches, liquids, suppositories, ovules, ointments and capsules. It enables better treatments for patients and improved efficiency for pharmacies and hospital pharmacies. In addition to cost savings, it ensures high manufacturing standards at the point of care through in-process quality control. The CSS is a user-friendly platform consisting of: GMP manufactured excipient bases, compounding robotics, integrated quality control tools, software and a comprehensive formulation library to meet versatile compounding needs of pharmacies.. CurifyLabs’ CSS technology is in use for patients by customers in 10 different markets in Europe and US.

 Press Releases

• CurifyLabs Signs Deal with Helios, Europe’s Leading Private Hospital Grou (May 13, 2025)

  At CurifyLabs, we are driving automation in non-sterile compounding, advancing personalized medicine, and enhancing precision and safety in healthcare.
  That’s why we are particularly excited about our collaboration with Helios Klinikum Erfurt, part of Helios Health, one of Europe’s leading private hospital groups. 
  Their commitment to innovation and trust in our technology reinforce our shared mission: improving pharmaceutical care.

  This week, we are working closely with the pharmacy team in Erfurt, led by the visionary Dr. D. Fenske, to seamlessly integrate our solution into their workflow. Their openness to new technologies and innovative approaches demonstrates how automation can drive efficiency, compliance, and patient safety in hospital pharmacies.

  We are proud to make a real impact in healthcare—and grateful for the fantastic collaboration with all involved!

• Press Release: Prinses Máxima Center Implements CurifyLabs' Compounding Te (May 13, 2025)

  3D-printed medication: personalized for every child

  20-02-2025

  The pharmacy of the Princess Máxima Center is ready to launch a groundbreaking innovation: 3D printing of medication. With this new technology, oral medication can be precisely customized to meet the needs of a child with cancer, improving adherence and making treatments more effective.

  Many oral medications are developed for adults and are not available in the correct dosage for children. Lidwien Hanff, Head of the Hospital Pharmacy, explains: ‘We are constantly challenged to find the smartest solutions for children. During intensive treatment with medication, chemotherapy, and immunotherapy, maintaining the child’s quality of life is crucial—this is also the Máxima Center’s mission. Our role is to advise on medication that prioritizes as much comfort as possible for the child.’

 Products